
OJSC "Pharmacy Network 36.6" against the backdrop of the global financial crisis optimizes the work of the pharmacy network, said Maxim Arkhipov, director of corporate finance and relations with the investors of the company.
According to him, "the company has various options for optimizing costs." One of the options is the closure of those pharmacies whose effectiveness is on a review. As the company claimed earlier, the share of such pharmacies "can be more than 2%.
According to Arkhipov, due to the crisis of the company’s investment program for 2009, it is unlikely to be increased in relation to 2008. He recalled that earlier the company planned to reduce the activity of mergers and acquisitions in 2008 and focus on reducing debt, and in 2009 to "return to the development market." "Given the conjuncture, we are unlikely to increase the program regarding 2008," he said.
According to Arkhipov, according to the results of 2008, the company sets itself the goal of getting an non -negative EBITDA indicator in retail. However, taking into account the situation in the market, "there is a possibility that we will not reach it."